Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

354 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Initial results in the assessment of multiple myeloma using 18F-FDG PET.
Schirrmeister H, Bommer M, Buck AK, Müller S, Messer P, Bunjes D, Döhner H, Bergmann L, Reske SN. Schirrmeister H, et al. Among authors: buck ak. Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):361-6. doi: 10.1007/s00259-001-0711-3. Eur J Nucl Med Mol Imaging. 2002. PMID: 12002711 Clinical Trial.
Biological characterisation of breast cancer by means of PET.
Buck AK, Schirrmeister H, Mattfeldt T, Reske SN. Buck AK, et al. Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S80-7. doi: 10.1007/s00259-004-1529-6. Epub 2004 May 4. Eur J Nucl Med Mol Imaging. 2004. PMID: 15127240 Review.
Clinical relevance of imaging proliferative activity in lung nodules.
Buck AK, Hetzel M, Schirrmeister H, Halter G, Möller P, Kratochwil C, Wahl A, Glatting G, Mottaghy FM, Mattfeldt T, Neumaier B, Reske SN. Buck AK, et al. Eur J Nucl Med Mol Imaging. 2005 May;32(5):525-33. doi: 10.1007/s00259-004-1706-7. Epub 2004 Dec 14. Eur J Nucl Med Mol Imaging. 2005. PMID: 15599526 Clinical Trial.
Direct comparison of [18F]FDG PET/CT with PET alone and with side-by-side PET and CT in patients with malignant melanoma.
Mottaghy FM, Sunderkötter C, Schubert R, Wohlfart P, Blumstein NM, Neumaier B, Glatting G, Ozdemir C, Buck AK, Scharffetter-Kochanek K, Reske SN. Mottaghy FM, et al. Among authors: buck ak. Eur J Nucl Med Mol Imaging. 2007 Sep;34(9):1355-64. doi: 10.1007/s00259-006-0358-1. Epub 2007 Feb 13. Eur J Nucl Med Mol Imaging. 2007. PMID: 17295038
Performance of integrated FDG-PET/CT for differentiating benign and malignant lung lesions--results from a large prospective clinical trial.
Pauls S, Buck AK, Halter G, Mottaghy FM, Muche R, Bluemel C, Gerstner S, Krüger S, Glatting G, Sunder-Plassmann L, Möller P, Brambs HJ, Reske SN. Pauls S, et al. Among authors: buck ak. Mol Imaging Biol. 2008 Mar-Apr;10(2):121-8. doi: 10.1007/s11307-007-0129-9. Epub 2008 Jan 16. Mol Imaging Biol. 2008. PMID: 18204955 Clinical Trial.
Imaging bone and soft tissue tumors with the proliferation marker [18F]fluorodeoxythymidine.
Buck AK, Herrmann K, Büschenfelde CM, Juweid ME, Bischoff M, Glatting G, Weirich G, Möller P, Wester HJ, Scheidhauer K, Dechow T, Peschel C, Schwaiger M, Reske SN. Buck AK, et al. Clin Cancer Res. 2008 May 15;14(10):2970-7. doi: 10.1158/1078-0432.CCR-07-4294. Epub 2008 Apr 29. Clin Cancer Res. 2008. PMID: 18445694 Clinical Trial.
SPECT/CT.
Buck AK, Nekolla S, Ziegler S, Beer A, Krause BJ, Herrmann K, Scheidhauer K, Wester HJ, Rummeny EJ, Schwaiger M, Drzezga A. Buck AK, et al. J Nucl Med. 2008 Aug;49(8):1305-19. doi: 10.2967/jnumed.107.050195. Epub 2008 Jul 16. J Nucl Med. 2008. PMID: 18632825 Free article.
354 results